Riskpilot← Back to searchSign inGet full accessMedpact AB
ABActiveOrg 5592261274Kalmargatan 52 BNon-specialised wholesale trade · NACE 4690Est. 20190 employees
Revenue 2024
SEK 288K
+99% vs 2023
EBITDA margin
23.7%
+6% vs 2023
Equity ratio
74.5%
Financial strength
Net profit 2024
SEK 45K
+75% vs 2023
| Revenue | SEK 288K | +99% |
| EBITDA | SEK 68K | +6% |
| Net profit | SEK 45K | +75% |
| Total assets | SEK 394K | +29% |
| Equity | SEK 293K | +18% |
| Employees | 0 | — |
Legal name
Medpact AB
Org number
5592261274
Legal form
Aktiebolag
NACE code
4690 · Non-specialised wholesale trade
Founded
11 november 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolagets skall, direkt eller indirekt genom dotterbolag, via distributörer bedriva försäljning av förbrukningsmaterial för industri som hanterar klinisk utrustning, så som sjukvård och laboratorier, samt idka därmed förenlig verksamhet.
Address
Kalmargatan 52 B
Email
dumont.richard@icloud.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 482 | 465 | 177 | 145 | 288 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 41 | 107 | 82 | 64 | 68 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 41 | 107 | 82 | 64 | 68 |
| Net financials | — | — | −1 | −3 | 0 |
| Profit before tax | 41 | 107 | 81 | 61 | 69 |
| Tax | −9 | −31 | −17 | −36 | −14 |
| Net profit | 32 | 76 | 64 | 26 | 45 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 151 | 363 | 279 | 305 | 394 |
| Equity | 82 | 159 | 223 | 249 | 293 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 69 | 205 | 56 | 57 | 100 |
| Total debt | 69 | 205 | 56 | 57 | 100 |
EBITDA margin
23.7%
This company
15.8%
Market median
+50% vs market
20202024
Equity ratio
74.5%
This company
38.2%
Market median
+95% vs market
20202024
Return on equity
15.3%
This company
18.4%
Market median
+17% vs market
20202024
Net profit margin
15.6%
This company
8.1%
Market median
+93% vs market
20202024
Asset turnover
0.73×
This company
1.12×
Market median
-35% vs market
20202024
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-11-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medpact AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Richard Pierre Dumont | Board of Directors | 0 companies |
| Jan Peter Jansson | Deputy Board Member | 0 companies |